// App-Quantinova.ai

969 ⋆ : Long‐Term Follow Up of Patients with Chronic HCV and No or Minimal Fibrosis Shows Low Risk for Liver‐Related Morbidity and Mortality After Achieving SVR with DAA‐Based Therapy: Results from the Gilead SVR Registry

Researchers

Presenter

  • Marc Bourlire

Principal Investigators

  • Edward J. Gane

  • ira Jacobson

  • Stuart C. Gordon

  • Mark S. Sulkowski

  • Brian L. McNabb

  • Frances Chen

  • Hadas Dvory-Sobol

  • John McNally

  • Diana M. Brainard

  • Mani Subramanian

  • Alnoor Ramji

  • Stefan Zeuzem

  • Kosh Agarwal

  • K. Rajender Reddy

Medical Centers

  • Department of Hepato‐Gastroenterology, Hôpital Saint‐Joseph Marseille, Marseille, France

  • New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand

  • Mount Sinai St. Lukes Hospital, Icahn School of Medicine at Mount Sinai, New York, NY

  • Henry Ford Health System, Detroit, MI

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Clinical Pharmacology, Gilead Sciences, Inc., Foster City, CA

  • Biostatistics, Gilead Sciences, Inc, Foster City, CA

  • Gilead Sciences, Inc., Foster City, CA

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Johann Wolfgang Goethe-University, Frankfurt, Germany.

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • University of Pennsylvania, Philadelphia, PA

Locations

  • France

  • New Zealand

  • United States

  • Canada

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Liver cancer

  • Hepatic encephalopathy

  • Encephalopathy

  • Solid malignancies

  • Hyperbilirubinemia

Biomarkers

  • Alanine transaminase

  • N-Acylethanolamine acid amidase

  • Aspartate aminotransferase

  • Human albumin

  • Sustained virological response

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved